COMMUNIQUÉS West-GlobeNewswire

Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class
23/05/2019
Late-Breaking Trial Session at EuroPCR Featured Positive Data on Helix System PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [OTC: BCDA], a leader in the development of comprehensive [...]
Annual General Meeting of Active Biotech AB
23/05/2019
PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 23, 2019. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The members of the Board and the [...]
Merus annonce son Assemblée générale annuelles des actionnaires 2019
23/05/2019
UTRECHT, Pays-Bas, 23 mai 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », « nous » ou la « Société »), société spécialisée en immuno-oncologie de stade clinique qui développe Biclonics®, un traitement [...]
Genkyotex Invites Shareholders to Annual General Meeting on June 13, 2019
23/05/2019
Documents related to AGM available on Genkyotex website or upon request Genkyotex advancing on strategy for further development of GKT831 in fibrotic liver diseases GKT831 Ph2 DKD trial progresses and Ph2 IPF trial [...]
Genkyotex invite ses actionnaires à l’Assemblée générale mixte du 13 juin 2019
23/05/2019
Modalités de mise à disposition des documents préparatoires Les informations et documents relatifs à l’Assemblée Générale sont disponibles sur simple demande ou peuvent être consultés sur le site internet de la Société [...]
Repeat: Inventiva announces that FDA lifts target class clinical hold which allows long-term clinical studies with lanifibranor in NASH
23/05/2019
Inventiva announces that FDA lifts target class clinical hold which allows long-term clinical studies with lanifibranor in NASH FDA decision based on the results of carcinogenicity studies Lanifibranor does not show any [...]
Repeat: Inventiva annonce que la FDA a levé la suspension clinique applicable aux agonistes PPAR ce qui permet de réaliser des études cliniques à long terme avec lanifibranor dans la NASH
23/05/2019
Inventiva annonce que la FDA a levé la suspension clinique applicable aux agonistes PPAR ce qui permet de réaliser des études cliniques à long terme avec lanifibranor dans la NASH La décision de la FDA est fondée sur [...]
Inventiva announces that FDA lifts target class clinical hold which allows long-term clinical studies with lanifibranor in NASH
23/05/2019
Inventiva announces that FDA lifts target class clinical hold which allows long-term clinical studies with lanifibranor in NASH FDA decision based on the results of carcinogenicity studies Lanifibranor does not show any [...]
Inventiva annonce que la FDA a levé la suspension clinique applicable aux agonistes PPAR ce qui permet de réaliser des études cliniques à long terme avec lanifibranor dans la NASH
23/05/2019
Inventiva annonce que la FDA a levé la suspension clinique applicable aux agonistes PPAR ce qui permet de réaliser des études cliniques à long terme avec lanifibranor dans la NASH La décision de la FDA est fondée sur [...]
Ahead of Memorial Day, the American Academy of Dermatology Reminds Americans to Use Protection
23/05/2019
Dermatologists urge the public to “practice safe sun” when outside this holiday weekend to reduce the risk of skin cancer ROSEMONT, Ill., May 23, 2019 (GLOBE NEWSWIRE) -- An estimated 9,500 people in the United States [...]
Nexstim Plc: Amendment of terms of warrants
23/05/2019
Company announcement, Helsinki, 23 May 2019 at 6.30 PM Nexstim Plc: Amendment of terms of warrants Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( "Nexstim" or "Company" ), the targeted neuromodulation company developing and [...]
Max Domi, vedette des Canadiens de Montréal et porte-parole national de FRDJ, se joindra le 28 mai à des enfants de la région de Montréal qui vivent avec le diabète de type 1 pour avoir une discussion franche sur la maladie
23/05/2019
Cette conversation unique organisée aux Salles de Bal Le Windsor à Montréal donnera la chance à 13 jeunes de la région de poser des questions à Max sur ses expériences avec le Diabète de type 1 et sa participation [...]
Montreal Canadiens star and JDRF National Spokesperson Max Domi joins Montreal-area kids living with type 1 diabetes May 28 for a frank discussion on the disease
23/05/2019
Hosted from the Windsor Ballrooms in Montreal, the unique conversation features 13 young Canadians interviewing Domi on his experiences with T1D and upcoming participating in the Sun Life Walk to Cure Diabetes for JDRF [...]
Robust Clinical Data and Positive Customer Experience with T2Bacteria and T2Candida Panels Highlighted at Recent Medical Meetings
23/05/2019
Presentations at ECCMID and MAD-ID meetings demonstrate clinically actionable results and cost savings achieved with these panels Real-world experience reinforces multi-day time advantage demonstrated in the T2Bacteria [...]
Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASCO to Discuss Interim Update of Data of CPI-0610 in MANIFEST Clinical Trial
23/05/2019
CAMBRIDGE, Mass., May 23, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Precipio CEO enrolls in long term stock purchase plan
23/05/2019
NEW HAVEN, Conn., May 23, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that, as previously stated, Ilan Danieli, Precipio’s CEO, has enrolled in a plan to [...]
Coherus BioSciences Announces New Employment Inducement Grants
23/05/2019
REDWOOD CITY, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective May 22, 2019, the compensation committee of the company’s board of directors granted 6 new [...]
Information regarding acquisition or disposal of a major holding
23/05/2019
Joint Stock Company “Grindeks” hereby informs that it has received notifications of a an acquisition of a major holding from “Liplat Holding” Ltd., where Kirovs Lipmans holds 43.33%, „Dashdirect Limited” holds 34.95%, [...]
Auris Medical Holding Ltd Provides Corporate Update
23/05/2019
Hamilton, Bermuda, May 23, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]

Pages